Diabetes (General) Clinical Trial Landscape
Data updated: May 20, 2026
1,605 clinical trials tracked since 2008
Diabetes encompasses a group of metabolic disorders characterized by elevated blood sugar levels, affecting a significant portion of the global population and requiring ongoing management to prevent serious health complications. The clinical trial landscape for diabetes is active, with 1,597 trials registered since 2008, including 185 currently recruiting, enrolling, or active but not recruiting. Activity is distributed across all phases of clinical development, with 43 active Phase 1 trials out of 495 total, 66 active Phase 2 trials out of 428 total, 45 active Phase 3 trials out of 403 total, and 53 active Phase 4 trials out of 396 total. This suggests a relatively even spread of research efforts across different stages of clinical development. Gan & Lee Pharmaceuticals leads industry sponsorship of active trials with 5, followed by Novo Nordisk, Jiangsu HengRui Medicine Co., Ltd., EMS, and AJU Pharm Co., Ltd., each with 2 active trials.
185 active
/
1605 total (since 2008)
41
Phase 1 Active
495 total
69
Phase 2 Active
433 total
44
Phase 3 Active
405 total
53
Phase 4 Active
398 total
Top Industry Sponsors
Sorted by active Active Done Failed
Gan & Lee Pharmaceuticals. 5 0 0
Novo Nordisk 2 274 4
Jiangsu HengRui Medicine Co., Ltd. 2 4 0
EMS 2 0 3
AJU Pharm Co., Ltd. 2 1 0
+ 10 more sponsors — see full table below
Featured Phase 3 Trials
NCT07284901 RECRUITING
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Kailera n=1,700
NCT02262832 ACTIVE NOT RECRUITING
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) n=24
NCT05427084 RECRUITING
Canagliflozin Targeting Vascular Inflammation
Ottawa Heart Institute Research Corporation n=24
NCT05569772 RECRUITING
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven n=252
NCT07533175 RECRUITING
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Novo Nordisk A/S n=630
+ 400 more Phase 3 trials — see full database below
Diabetes (General) — Trials Started by Year (last 10 years)
2016 93
2017 100
2018 84
2019 63
2020 41
2021 59
2022 42
2023 43
2024 56
2025 61
2026 30
TheraRadar.com
Full Trial Database
Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.
Top Sponsors (all-time)
Gan & Lee Pharmaceuticals. 5
Novo Nordisk 280
Jiangsu HengRui Medicine Co., Ltd. 6
EMS 5
AJU Pharm Co., Ltd. 3
Sun Pharmaceutical Industries Limited 2
AstraZeneca 26
Eli Lilly 19
Pfizer 15
HK inno.N Corporation 5
Active Trials by Phase
Phase 1 41
Phase 2 69
Phase 3 44
Phase 4 53
Enrollment Size Distribution
1-50 694
51-200 501
201-500 204
501-1k 81
1k+ 51
All Industry Sponsors
Sorted by active Active Done Failed
Gan & Lee Pharmaceuticals. 5 0 0
Novo Nordisk 2 274 4
Jiangsu HengRui Medicine Co., Ltd. 2 4 0
EMS 2 0 3
AJU Pharm Co., Ltd. 2 1 0
Sun Pharmaceutical Industries Limited 2 0 0
AstraZeneca 1 22 3
Eli Lilly 1 18 0
Pfizer 1 13 1
HK inno.N Corporation 1 4 0
Boryung Pharmaceutical Co., Ltd 1 4 0
Khondrion BV 1 1 0
Getz Pharma 1 1 0
Energenesis Biomedical Co., Ltd. 1 1 0
Kailera 1 0 0
NCT07284901 RECRUITING
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Kailera n=1,700
NCT02262832 ACTIVE NOT RECRUITING
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) n=24
NCT05427084 RECRUITING
Canagliflozin Targeting Vascular Inflammation
Ottawa Heart Institute Research Corporation n=24
NCT05569772 RECRUITING
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven n=252
NCT07533175 RECRUITING
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Novo Nordisk A/S n=630
NCT07400653 RECRUITING
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
Pfizer n=999
NCT05174052 RECRUITING
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
University of Oklahoma n=28
NCT06217302 RECRUITING
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Alessandro Doria n=150
NCT07475065 NOT YET RECRUITING
The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy
Universitas Sebelas Maret n=34
NCT07391319 RECRUITING
The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial
JSC NextGen n=144
NCT06451757 RECRUITING
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Khondrion BV n=220
NCT07308184 NOT YET RECRUITING
Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone
HK inno.N Corporation n=110
NCT05305794 RECRUITING
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
Centre Hospitalier Universitaire Dijon n=76
NCT07279909 ACTIVE NOT RECRUITING
Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation
Hamdard University n=500
NCT05028140 RECRUITING
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
EMS n=480
NCT04602754 RECRUITING
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
EMS n=228
NCT06767735 ACTIVE NOT RECRUITING
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. n=580
NCT07165223 RECRUITING
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Gan & Lee Pharmaceuticals. n=300
NCT06767761 ACTIVE NOT RECRUITING
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin
Gan & Lee Pharmaceuticals. n=580
NCT06767748 ACTIVE NOT RECRUITING
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Gan & Lee Pharmaceuticals. n=620
NCT05887271 RECRUITING
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
University of Leicester n=63
NCT05930210 RECRUITING
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Energenesis Biomedical Co., Ltd. n=230
NCT06257966 ACTIVE NOT RECRUITING
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
Beijing Dongfang Biotech Co., Ltd. n=600
NCT05852054 ACTIVE NOT RECRUITING
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
Northwestern University n=1,500
NCT06909006 NOT YET RECRUITING
Semaglutide Treatment in Type 1 Diabetes
Nordsjaellands Hospital n=122
NCT07073768 ENROLLING BY INVITATION
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
Khyber Medical College, Peshawar n=126
NCT06535789 RECRUITING
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Jaeb Center for Health Research n=30
NCT06946628 NOT YET RECRUITING
New Triple Therapy in Newly Diagnosed Type 2 Diabetes
Sun Yat-sen University n=296
NCT06286878 RECRUITING
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
University of Sao Paulo n=80
NCT06801886 ENROLLING BY INVITATION
Silymarin's Advantage on Graft Effectiveness
University Hospital, Martin n=130
NCT06894784 RECRUITING
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre n=36
NCT06847178 NOT YET RECRUITING
Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes
Shanghai Changzheng Hospital n=60
NCT06619600 ACTIVE NOT RECRUITING
Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction
Hospital Clinic of Barcelona n=54
NCT06820567 NOT YET RECRUITING
Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD
Assiut University n=210
NCT06387199 RECRUITING
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
McGill University Health Centre/Research Institute of the McGill University Health Centre n=26
NCT05073835 ACTIVE NOT RECRUITING
Semaglutide 2.4 mg in Patients With Poor Weight-loss
University College, London n=70
NCT05769868 RECRUITING
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
Consorcio Centro de Investigación Biomédica en Red (CIBER) n=1,000
NCT03982693 RECRUITING
Trial to Assess Chelation Therapy in Critical Limb Ischemia
Mt. Sinai Medical Center, Miami n=50
NCT06430125 RECRUITING
Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus
Tanta University n=46
NCT04581447 RECRUITING
Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care
Assistance Publique - Hôpitaux de Paris n=126
NCT02947503 RECRUITING
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Bethesda Diabetes Research Center n=500
NCT07586371 ACTIVE NOT RECRUITING
Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i
Dr Mudassar Saeed Pansota n=60
NCT03313752 COMPLETED
Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
Giaccari Andrea n=25
NCT02042664 COMPLETED
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
Assistance Publique Hopitaux De Marseille n=44
NCT04181996 COMPLETED
Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
Ottawa Heart Institute Research Corporation n=115
NCT05802862 COMPLETED
A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China
Sunshine Lake Pharma Co., Ltd. n=414
NCT01812694 COMPLETED
Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) n=123
NCT06340854 COMPLETED
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Novo Nordisk A/S n=429
NCT03574909 COMPLETED
IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes
Royal College of Surgeons, Ireland n=137
NCT06354660 COMPLETED
Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Eli Lilly and Company n=537
NCT02546401 COMPLETED
Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump
University Hospital, Brest n=22
NCT05260021 COMPLETED
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Eli Lilly and Company n=99
NCT03071692 TERMINATED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Kowa Research Institute, Inc. n=10,544
NCT02375828 COMPLETED
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
Assistance Publique - Hôpitaux de Paris n=10
NCT01731431 COMPLETED
Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes
Assistance Publique - Hôpitaux de Paris n=914
NCT05691712 COMPLETED
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Eli Lilly and Company n=257
NCT01219959 COMPLETED
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
Vantive Health LLC n=71
NCT00567398 COMPLETED
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
Vantive Health LLC n=43
NCT05463744 COMPLETED
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
Eli Lilly and Company n=692
NCT05362058 COMPLETED
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
Eli Lilly and Company n=928
NCT06952231 COMPLETED
Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus
University of Lahore n=50
NCT05280496 COMPLETED
A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes
Tufts Medical Center n=20
NCT06912035 COMPLETED
Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang
Universitas Sriwijaya n=34
NCT04965935 COMPLETED
Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients
University Health Network, Toronto n=52
NCT02980276 COMPLETED
RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects
National University of Ireland, Galway, Ireland n=535
NCT03215069 COMPLETED
Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes
Mount Sinai Hospital, Canada n=91
NCT04409795 COMPLETED
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
Joslin Diabetes Center n=3
NCT06770894 COMPLETED
DPP4-Inhibitors and Bone Metabolism in Diabetes
Azienda Policlinico Umberto I n=132
NCT04998032 COMPLETED
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. n=620
NCT04233034 COMPLETED
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
Jaeb Center for Health Research n=113
NCT01514838 TERMINATED
A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
Astellas Pharma Inc n=46
NCT01505426 COMPLETED
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
Astellas Pharma Inc n=171
NCT04994288 COMPLETED
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. n=547
NCT05364190 COMPLETED
Canagliflozin in Patients With Acute Decompansted Heart Failure
October 6 University n=142
NCT03380546 TERMINATED
Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.
Assistance Publique - Hôpitaux de Paris n=341
NCT03324776 COMPLETED
Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients
Model Clinical Research LLC n=20
NCT04809220 COMPLETED
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Eli Lilly and Company n=591
NCT00862251 COMPLETED
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
Organon and Co n=808
NCT03466866 COMPLETED
Reducing Emergency Diabetes Care for Older African Americans
Thomas Jefferson University n=156
NCT06329674 COMPLETED
Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients
AJU Pharm Co., Ltd. n=235
NCT04636411 COMPLETED
Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes
Samar Fares, MD n=80
NCT01817959 COMPLETED
Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation
Dompé Farmaceutici S.p.A n=51
NCT02491528 COMPLETED
A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety
Tonghua Dongbao Pharmaceutical Co.,Ltd n=563
NCT01331681 COMPLETED
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
Bayer n=406
NCT06127355 COMPLETED
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia n=113
NCT03784443 WITHDRAWN
Combined Ranibizumab and Iluvien for Diabetic Macular Oedema
Imperial College London
NCT05094401 TERMINATED
Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes
Better Therapeutics n=76
NCT04970108 WITHDRAWN
Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension
EMS
NCT05144360 WITHDRAWN
Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension
EMS
NCT02932475 TERMINATED
Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)
University of North Carolina, Chapel Hill n=831
NCT01308437 TERMINATED
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Wockhardt n=134
NCT02947620 COMPLETED
Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
Daewoong Pharmaceutical Co. LTD. n=185
NCT01100892 COMPLETED
Cystic Fibrosis - Insulin Deficiency, Early Action
Sydney Children's Hospitals Network n=100
NCT04885712 COMPLETED
A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Boryung Pharmaceutical Co., Ltd n=378
NCT03770767 COMPLETED
Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes
Rigshospitalet, Denmark n=216
NCT04762719 COMPLETED
PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
Mayo Clinic n=12
NCT03174522 TERMINATED
The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
Ixaka Ltd n=49
NCT03377699 COMPLETED
Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes
Novo Nordisk A/S n=225
NCT03172494 COMPLETED
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Novo Nordisk A/S n=720
NCT03344692 COMPLETED
Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes
Nantes University Hospital n=22
NCT01485614 COMPLETED
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Merck Sharp & Dohme LLC n=200
NCT03151343 COMPLETED
SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk
Caroline M Kistorp n=92
NCT03766750 WITHDRAWN
Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.
EMS
NCT02863419 COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=711
NCT02863328 COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=822
NCT02607865 COMPLETED
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=1,864
NCT02849080 COMPLETED
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
Novo Nordisk A/S n=504
NCT02906930 COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
Novo Nordisk A/S n=703
NCT02692716 COMPLETED
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=3,183
NCT03979352 COMPLETED
Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting
Samuel Lunenfeld Research Institute, Mount Sinai Hospital n=28
NCT03078478 COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
Novo Nordisk A/S n=1,609
NCT03268005 COMPLETED
Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes
Novo Nordisk A/S n=1,264
NCT03420781 TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Allergan n=467
NCT04170998 COMPLETED
Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Dong-A ST Co., Ltd. n=283
NCT03383146 TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Allergan n=450
NCT01818310 COMPLETED
Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia
University Hospital Ostrava n=80
NCT04674332 COMPLETED
Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus
Ain Shams University n=148
NCT05038046 COMPLETED
Combined Western and Traditional Chinese Medicine Daycare for DM Nephropathy Patients
China Medical University Hospital n=25
NCT03739125 COMPLETED
Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
Chong Kun Dang Pharmaceutical n=226
NCT03426345 TERMINATED
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
Allergan n=311
NCT03285308 TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
Allergan n=336
NCT03259789 COMPLETED
Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Theracos n=351
NCT01541215 COMPLETED
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S n=135
NCT03086330 COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=302
NCT03480022 COMPLETED
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
Woman's n=88
NCT04371978 TERMINATED
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
Rabin Medical Center n=64
NCT00814294 COMPLETED
Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus
Diasome Pharmaceuticals n=239
NCT03026426 COMPLETED
Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru
Universidad Peruana Cayetano Heredia n=432
NCT03111238 TERMINATED
The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
Ixaka Ltd n=3
NCT02607306 COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Novo Nordisk A/S n=819
NCT02911948 COMPLETED
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
Novo Nordisk A/S n=210
NCT03061214 COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
Novo Nordisk A/S n=868
NCT03015220 COMPLETED
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S n=458
NCT01644201 TERMINATED
A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics
InovoBiologic Inc. n=100
NCT03018028 COMPLETED
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S n=243
NCT01002209 WITHDRAWN
Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery
Karolinska Institutet
NCT02964247 COMPLETED
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
Novo Nordisk A/S n=303
NCT02032173 TERMINATED
Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase
Novartis Pharmaceuticals n=31
NCT02592421 COMPLETED
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
The University of Texas Health Science Center at San Antonio n=30
NCT03374176 COMPLETED
Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes
Centro Universitario de Tonalá n=42
NCT02773368 COMPLETED
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=420
NCT03651531 TERMINATED
Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus
Women and Infants Hospital of Rhode Island n=1
NCT04079413 COMPLETED
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
Geropharm n=264
NCT02183935 COMPLETED
Treatment of Morbidly Obese Adolescent With a Duodena-jejunal Liner
University Medical Centre Ljubljana n=22
NCT02419612 COMPLETED
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
AstraZeneca n=444
NCT04361552 WITHDRAWN
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Emory University
NCT03430856 COMPLETED
Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
Biocon Limited n=143
NCT04069234 WITHDRAWN
Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.
Region Skane
NCT03175120 COMPLETED
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
Novo Nordisk A/S n=453
NCT03116009 TERMINATED
Randomization of Early Diabetes Screening Among Obese Pregnant Women.
University of Illinois at Chicago n=600
NCT03021187 COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Novo Nordisk A/S n=731
NCT03173963 WITHDRAWN
Empaglifozin in Early Diabetic Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT02827708 COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Novo Nordisk A/S n=324
NCT03136484 COMPLETED
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=788
NCT01730534 COMPLETED
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
AstraZeneca n=17,190
NCT01369069 COMPLETED
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
University of Virginia n=1,151
NCT02984644 COMPLETED
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
The University of Texas Health Science Center at San Antonio n=30
NCT02501161 COMPLETED
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=1,012
NCT02825251 COMPLETED
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
Novo Nordisk A/S n=472
NCT02906917 COMPLETED
A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
Novo Nordisk A/S n=532
NCT03191396 COMPLETED
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
Novo Nordisk A/S n=577
NCT02648204 COMPLETED
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Novo Nordisk A/S n=1,201
NCT02171130 COMPLETED
Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
Eli Lilly and Company n=129
NCT03433677 COMPLETED
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
Eli Lilly and Company n=49
NCT03421379 COMPLETED
A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus
Eli Lilly and Company n=75
NCT02402933 COMPLETED
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
Eli Lilly and Company n=26
NCT01959334 COMPLETED
Evaluate the Immunogenicity of a Novel Glucagon Formulation
Eli Lilly and Company n=75
NCT03565666 COMPLETED
The Insulin-Only Bionic Pancreas Bridging Study
Massachusetts General Hospital n=36
NCT02752113 COMPLETED
Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
Institut für Pharmakologie und Präventive Medizin n=101
NCT01234649 COMPLETED
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Woman's n=153
NCT01959529 COMPLETED
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
Novo Nordisk A/S n=7,637
NCT04023344 COMPLETED
Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients
Geropharm n=210
NCT04022993 COMPLETED
Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients
Geropharm n=180
NCT01179048 COMPLETED
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
Novo Nordisk A/S n=9,341
NCT03289338 COMPLETED
Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus
Post Graduate Institute of Medical Education and Research, Chandigarh n=36
NCT00784433 COMPLETED
The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial
Ben-Gurion University of the Negev n=224
NCT02735837 COMPLETED
The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®
Amirhossein Farahmand n=24
NCT01720446 COMPLETED
Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=3,297
NCT01236365 COMPLETED
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Nemours Children's Clinic n=42
NCT01513473 COMPLETED
A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus
Novo Nordisk A/S n=350
NCT02128932 COMPLETED
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S n=1,089
NCT01930188 COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=1,231
NCT01885208 COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=813
NCT01831765 COMPLETED
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
Novo Nordisk A/S n=1,290
NCT01850615 COMPLETED
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
Novo Nordisk A/S n=323
NCT02054897 COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S n=388
NCT02500706 COMPLETED
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
Novo Nordisk A/S n=1,108
NCT02305381 COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=397
NCT01835431 COMPLETED
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Novo Nordisk A/S n=362
NCT02338193 COMPLETED
Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women
Woman's n=69
NCT02670915 COMPLETED
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Novo Nordisk A/S n=834
NCT02030600 COMPLETED
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=721
NCT02762578 COMPLETED
Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=543
NCT01513590 COMPLETED
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S n=394
NCT01620489 COMPLETED
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Novo Nordisk A/S n=279
NCT03851055 COMPLETED
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus
Ain Shams University n=80
NCT03841591 COMPLETED
Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
Ain Shams University n=124
NCT01819129 COMPLETED
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
Novo Nordisk A/S n=881
NCT02229383 COMPLETED
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
AstraZeneca n=464
NCT02207374 COMPLETED
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S n=601
NCT01952145 COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=557
NCT01392573 COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=413
NCT01676116 COMPLETED
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Novo Nordisk A/S n=438
NCT02034513 COMPLETED
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
Novo Nordisk A/S n=501
NCT02229396 COMPLETED
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
AstraZeneca n=695
NCT01059812 COMPLETED
A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes
Novo Nordisk A/S n=424
NCT01009580 COMPLETED
Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Novo Nordisk A/S n=447
NCT03745300 COMPLETED
Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.
Government Dental College and Research Institute, Bangalore n=120
NCT02846662 COMPLETED
Effectiveness of a Mobile Technology Intervention for the Treatment of Depression
University of Sao Paulo General Hospital n=880
NCT02586129 COMPLETED
Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
Yuhan Corporation n=249
NCT02254291 COMPLETED
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S n=308
NCT02648217 COMPLETED
Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan
Novo Nordisk A/S n=263
NCT02131272 TERMINATED
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
Novo Nordisk A/S n=42
NCT01814748 COMPLETED
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
Merck Sharp & Dohme LLC n=203
NCT02505334 COMPLETED
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Novo Nordisk A/S n=635
NCT01030770 COMPLETED
Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:
King's College Hospital NHS Trust n=25
NCT02145988 TERMINATED
DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease
Dexa Medica Group n=11
NCT01814267 COMPLETED
Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management
University Hospital, Grenoble n=14
NCT02471963 COMPLETED
Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
University of Erlangen-Nürnberg Medical School n=74
NCT02383238 COMPLETED
Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
University of Erlangen-Nürnberg Medical School n=59
NCT01215331 COMPLETED
Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
Université de Sherbrooke n=73
NCT02478762 TERMINATED
Glycemic Objectives of Women With Gestational Diabetes Mellitus
Université de Sherbrooke n=5
NCT01581073 COMPLETED
PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan n=476
NCT00787306 COMPLETED
Cardiovascular Health And Risk Modification in Family Health Teams
University of Toronto n=229
NCT01680341 COMPLETED
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Novo Nordisk A/S n=272
NCT01713530 COMPLETED
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Novo Nordisk A/S n=274
NCT02420262 COMPLETED
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=506
NCT01336023 COMPLETED
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=1,663
NCT01572740 COMPLETED
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S n=257
NCT01217307 COMPLETED
Metformin to Reduce Heart Failure After Myocardial Infarction
University Medical Center Groningen n=380
NCT01835678 COMPLETED
Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
University of Erlangen-Nürnberg Medical School n=65
NCT01803711 TERMINATED
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
UConn Health n=6
NCT01512108 COMPLETED
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Novo Nordisk A/S n=363
NCT01999322 COMPLETED
A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes
Novo Nordisk A/S n=37
NCT03320694 COMPLETED
Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus
Services Institute of Medical Sciences, Pakistan n=278
NCT01618162 COMPLETED
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Novo Nordisk A/S n=435
NCT01664247 COMPLETED
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Novo Nordisk A/S n=346
NCT00955903 COMPLETED
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
University of Alabama at Birmingham n=167
NCT02484209 WITHDRAWN
DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)
Diabetes Frail Ltd
NCT01754259 COMPLETED
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
Brigham and Women's Hospital n=47
NCT01208558 COMPLETED
Grain Exercise Trial - Whole Grain Versus no Grain With or Without Physiotherapy-promoted Exercise for Waist Loss
Lund University n=105
NCT02298192 COMPLETED
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Novo Nordisk A/S n=420
NCT00837577 COMPLETED
MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
Merck Sharp & Dohme LLC n=133
NCT02371759 COMPLETED
Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2
University of Belgrade n=256
NCT01777282 COMPLETED
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
GlaxoSmithKline n=374
NCT01784965 COMPLETED
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
Stanford University n=69
NCT01774474 COMPLETED
PRevention of Macular EDema After Cataract Surgery
Maastricht University Medical Center n=1,127
NCT02077309 TERMINATED
Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus
RWTH Aachen University n=4
NCT01888796 TERMINATED
Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
RWTH Aachen University n=8
NCT01849289 COMPLETED
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S n=833
NCT00972283 COMPLETED
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
Novo Nordisk A/S n=1,006
NCT00982228 COMPLETED
Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes
Novo Nordisk A/S n=629
NCT01059799 COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=435
NCT00773279 COMPLETED
Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics
Novo Nordisk A/S n=242
NCT01814137 COMPLETED
A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily
Novo Nordisk A/S n=40
NCT01045447 COMPLETED
Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=465
NCT00978627 COMPLETED
Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
Novo Nordisk A/S n=548
NCT01365507 COMPLETED
Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
Novo Nordisk A/S n=276
NCT01272193 COMPLETED
Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes
Novo Nordisk A/S n=296
NCT02622672 COMPLETED
Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes
Yeh n=50
NCT00789191 COMPLETED
Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes
Novo Nordisk A/S n=222
NCT00701090 COMPLETED
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
Merck Sharp & Dohme LLC n=1,035
NCT01162876 COMPLETED
A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
Kyowa Kirin Co., Ltd. n=20
NCT00856986 COMPLETED
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=987
NCT00700817 COMPLETED
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=665
NCT00614120 COMPLETED
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=929
NCT01617434 COMPLETED
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=451
NCT00620282 COMPLETED
The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=49
NCT01570751 COMPLETED
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Novo Nordisk A/S n=145
NCT01074268 COMPLETED
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
Novo Nordisk A/S n=456
NCT01068678 COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=460
NCT01836523 COMPLETED
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Novo Nordisk A/S n=1,398
NCT01076647 COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=467
NCT01364428 COMPLETED
Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=373
NCT01326026 COMPLETED
Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S n=222
NCT01388361 COMPLETED
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
Novo Nordisk A/S n=413
NCT01068665 COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=460
NCT01046110 COMPLETED
Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin
Novo Nordisk A/S n=458
NCT01691846 COMPLETED
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Hoffmann-La Roche n=200
NCT02297399 COMPLETED
Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients
Parc de Salut Mar n=158
NCT02144948 COMPLETED
Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
GWT-TUD GmbH n=10
NCT01880736 COMPLETED
A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes
Novo Nordisk A/S n=458
NCT01006291 COMPLETED
Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes
Novo Nordisk A/S n=687
NCT01079234 COMPLETED
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
Novo Nordisk A/S n=493
NCT00982644 COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=1,030
NCT02098395 COMPLETED
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Novo Nordisk A/S n=835
NCT02100475 COMPLETED
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
Novo Nordisk A/S n=31
NCT02662400 COMPLETED
Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies
Post Graduate Institute of Medical Education and Research, Chandigarh n=7
NCT01705639 COMPLETED
Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene
University of Helsinki n=45
NCT01045707 COMPLETED
Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=530
NCT02080377 COMPLETED
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS
University of Edinburgh n=23
NCT02985099 COMPLETED
1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus
Government Dental College and Research Institute, Bangalore n=80
NCT01890122 COMPLETED
Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes
Takeda n=647
NCT00623194 COMPLETED
Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689
Novo Nordisk A/S n=146
NCT00763815 COMPLETED
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
Sanofi n=484
NCT00651105 COMPLETED
Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects
Novartis n=63
NCT01262586 COMPLETED
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
Novartis Pharmaceuticals n=24
NCT02568501 COMPLETED
Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults
University of Pennsylvania n=90
NCT00754988 COMPLETED
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Hoffmann-La Roche n=666
NCT00809705 COMPLETED
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
Hoffmann-La Roche n=60
NCT01691989 COMPLETED
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
Hoffmann-La Roche n=197
NCT01042769 COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Hoffmann-La Roche n=7,226
NCT00717457 COMPLETED
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Hoffmann-La Roche n=1,189
NCT01893242 WITHDRAWN
A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)
Hoffmann-La Roche
NCT01871428 COMPLETED
A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy
Hoffmann-La Roche n=13
NCT00909597 COMPLETED
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
Hoffmann-La Roche n=756
NCT01018173 COMPLETED
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Hoffmann-La Roche n=2,118
NCT01871415 COMPLETED
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy
Hoffmann-La Roche n=7
NCT01715818 COMPLETED
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Hoffmann-La Roche n=1,999
NCT01051011 TERMINATED
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy
Hoffmann-La Roche n=370
NCT01323348 COMPLETED
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control
Jaeb Center for Health Research n=1,875
NCT01691755 COMPLETED
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Hoffmann-La Roche n=196
NCT00744367 COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Hoffmann-La Roche n=326
NCT00755287 COMPLETED
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
Hoffmann-La Roche n=1,072
NCT00823992 COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Hoffmann-La Roche n=305
NCT00744926 COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
Hoffmann-La Roche n=373
NCT02213159 COMPLETED
Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery
American University of Beirut Medical Center n=60
NCT00836329 COMPLETED
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
National Heart, Lung, and Blood Institute (NHLBI) n=133
NCT01829464 TERMINATED
TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes
Takeda n=90
NCT01589757 COMPLETED
MAIN STUDY: Low Glycaemic Index (GI) Diet in the Management of GDM SUB-STUDY: The Breast Milk Sub-Study
University of Toronto n=99
NCT01220310 COMPLETED
Doctors and Web-based Self-management Support Pilot Study
Stanford University n=57
NCT02073188 COMPLETED
Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood Glucose
Sanofi n=186
NCT02729441 COMPLETED
Perindopril vs Ramipril for Persistence in MAU Reduction Study
Sunnybrook Health Sciences Centre n=23
NCT01334125 COMPLETED
Adjunctive Metformin Therapy in Double Diabetes
University of Massachusetts, Worcester n=28
NCT01228032 COMPLETED
The Health Outcomes Management and Evaluation (HOME) Study
Emory University n=447
NCT01569841 COMPLETED
A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes
Novo Nordisk A/S n=24
NCT00829296 COMPLETED
Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries
University of Chicago n=70
NCT01135992 COMPLETED
Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
Novo Nordisk A/S n=143
NCT00683735 COMPLETED
Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis
Michael A. Nauck n=20
NCT02616809 COMPLETED
Effects of Standing and Light-intensity Activity on Ambulatory Blood Pressure and Blood Glucose
Arizona State University n=10
NCT01652729 COMPLETED
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
AstraZeneca n=365
NCT02189005 COMPLETED
Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels
Joe Fenn n=210
NCT00754741 COMPLETED
Multi-arm Intervention Diabetes Adherence Study
Henry Ford Health System n=1,692
NCT01496430 TERMINATED
Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
Takeda n=105
NCT00594399 COMPLETED
Enhancing Fitness in Older Pre-diabetic Veterans
US Department of Veterans Affairs n=302
NCT01020955 COMPLETED
Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)
Karolinska University Hospital n=14
NCT01170442 TERMINATED
Does Vitamin D Improve Glycemic Control in Type II DM?
King Faisal Specialist Hospital & Research Center n=25
NCT02092896 COMPLETED
Liraglutide as add-on to Insulin in Type 1 Diabetes
Hvidovre University Hospital n=40
NCT01361594 COMPLETED
Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery
Emory University n=338
NCT02227212 COMPLETED
Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM
Sanofi n=40
NCT02294643 COMPLETED
Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
Seoul National University Bundang Hospital n=220
NCT01695278 COMPLETED
A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community
Northwestern University n=16
NCT01248143 COMPLETED
Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases
The Touro College and University System n=300
NCT00627445 COMPLETED
Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S n=441
NCT00700622 TERMINATED
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
Mannkind Corporation n=130
NCT01645332 COMPLETED
Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus
Dexa Medica Group n=104
NCT00935766 TERMINATED
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
Denver Health and Hospital Authority n=76
NCT01216618 COMPLETED
Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies
Insuline Medical Ltd. n=55
NCT01629199 COMPLETED
Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
Daewoong Pharmaceutical Co. LTD. n=176
NCT00989339 WITHDRAWN
Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers
Emory University
NCT02137174 COMPLETED
Home and School Visits Intervention for Children With DM TYPE 1
Ben-Gurion University of the Negev n=92
NCT01062763 COMPLETED
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
Ib Abildgaard Jacobsen n=119
NCT02122874 COMPLETED
Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients
Hospital General Universitario Elche n=60
NCT01456130 COMPLETED
Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes
Takeda n=67
NCT00910780 WITHDRAWN
Metabolic Effects of Antipsychotic Substitution in Children
Washington University School of Medicine
NCT01093651 COMPLETED
Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV
Washington University School of Medicine n=20
NCT01319357 COMPLETED
Effects of Saxagliptin on Endothelial Function
University of Erlangen-Nürnberg Medical School n=52
NCT00997282 COMPLETED
A Study of OPC-262 in Patients With Type 2 Diabetes
Kyowa Kirin Co., Ltd. n=255
NCT01193179 COMPLETED
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
Kyowa Kirin Co., Ltd. n=450
NCT01634282 COMPLETED
Along-term Study of OPC-262 in Patients With Type 2 Diabetes
Kyowa Kirin Co., Ltd. n=222
NCT00808431 COMPLETED
ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity
Vanderbilt University n=100
NCT01294436 COMPLETED
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
AstraZeneca n=728
NCT00959595 COMPLETED
Improvement of Sensibility in the Foot in Diabetic Patients Induced by EMLA-application to the Lower Leg
Lund University Hospital n=32
NCT01586481 COMPLETED
Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers
Assistance Publique - Hôpitaux de Paris n=33
NCT01610934 COMPLETED
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
University Hospital, Gentofte, Copenhagen n=15
NCT01915550 COMPLETED
Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy
Ain Shams University n=90
NCT01032395 COMPLETED
Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Chiltern Pesquisa Clinica Ltda n=342
NCT01472614 COMPLETED
Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus
Dexa Medica Group n=54
NCT00707993 COMPLETED
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
Takeda n=441
NCT00984750 COMPLETED
Acetyl-L-Carnitine in Type 2 Diabetes
Mario Negri Institute for Pharmacological Research n=229
NCT01370707 COMPLETED
A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients
HK inno.N Corporation n=187
NCT01398670 WITHDRAWN
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
Wockhardt
NCT00660075 COMPLETED
Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes
Laval University n=36
NCT01280188 COMPLETED
A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Ferring Pharmaceuticals n=20
NCT00826774 COMPLETED
Improving the Management of Obesity in Primary Care Practice (The Power-UP Trial)
University of Pennsylvania n=390
NCT01092390 COMPLETED
Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease
Johns Hopkins University n=31
NCT01585051 COMPLETED
Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D
Kantonsspital Baselland Bruderholz n=51
NCT00947557 TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
Forest Laboratories n=677
NCT00970424 TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
Forest Laboratories n=252
NCT01422668 COMPLETED
Effect of Coffee Consumption on the Glycemic Index of Khalas Dates Tested in Healthy and Diabetic Subjects
United Arab Emirates University n=23
NCT00569595 COMPLETED
Improving Health Habits in Impoverished Populations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) n=100
NCT01309620 COMPLETED
Zinc Supplementation in Type 2 Diabetics
National University Hospital, Singapore n=40
NCT00993720 COMPLETED
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
Hvidovre University Hospital n=30
NCT01113671 COMPLETED
Type 2 Diabetes Haptoglobin Phenotype and Vitamin E
Technion, Israel Institute of Technology n=90
NCT00940472 COMPLETED
Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients
Laboratorios Silanes S.A. de C.V. n=20
NCT00804414 COMPLETED
Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers
Biotec Pharmacon ASA n=133
NCT01019642 COMPLETED
Vitamin D, C-reactive Protein and Insulin Resistance
Instituto Nacional de Salud Publica, Mexico n=104
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only